General form of registration statement for all companies including face-amount certificate companies

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY

v3.22.4
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Additional paid-in capital
Accumulated deficit
Total
Beginning Balances at Dec. 31, 2019 $ 7 $ 6,710 $ 3,348 $ 10,065
Beginning Balances (in shares) at Dec. 31, 2019 6,959,063      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Exercise of stock options   19   19
Exercise of stock options (in shares) 10,000      
Share issuance, net $ 3 9,612   9,615
Share issuance, net (in shares) 3,296,725      
Stock-based compensation   548   548
Equity component of debenture issuance   961   961
Settlement of performance share liability $ 1 13,338   13,339
Settlement of performance share liability (in shares) 1,000,000      
Net income (loss)     (15,036) (15,036)
Ending Balance at Dec. 31, 2020 $ 11 30,886 (11,688) 19,209
Ending Balance (in shares) at Dec. 31, 2020 11,275,788      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Exercise of stock options   19   19
Exercise of stock options (in shares) 3,000      
Share issuance, net $ 1 3,105   3,106
Share issuance, net (in shares) 503,148      
Stock-based compensation   818   818
Convertible debt converted into common shares   60   60
Convertible debt converted into common shares (in shares) 13,384      
Equity component of debenture issuance   1,204   1,204
Settlement of performance share liability   2,293   2,293
Settlement of performance share liability (in shares) 43,968      
Other (in shares) 15      
Net income (loss)     (2,447) (2,447)
Ending Balance at Sep. 30, 2021 $ 12 38,385 (14,135) 24,262
Ending Balance (in shares) at Sep. 30, 2021 11,839,304      
Beginning Balances at Dec. 31, 2020 $ 11 30,886 (11,688) 19,209
Beginning Balances (in shares) at Dec. 31, 2020 11,275,788      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Exercise of stock options   19   19
Exercise of stock options (in shares) 3,000      
Share issuance, net $ 1 5,061   5,062
Share issuance, net (in shares) 1,150,594      
Stock-based compensation   1,913   1,913
Convertible debt converted into common shares   60   60
Convertible debt converted into common shares (in shares) 13,384      
Equity component of debenture issuance   1,203   1,203
Settlement of performance share liability   2,293   2,293
Settlement of performance share liability (in shares) 43,968      
Other (in shares) 15      
Net income (loss)     (2,756) (2,756)
Ending Balance at Dec. 31, 2021 $ 13 43,387 (14,444) 28,956
Ending Balance (in shares) at Dec. 31, 2021 12,918,866      
Beginning Balances at Jun. 30, 2021 $ 12 38,136 (14,226) 23,922
Beginning Balances (in shares) at Jun. 30, 2021 11,833,431      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Exercise of stock options   19   19
Exercise of stock options (in shares) 3,000      
Stock-based compensation   210   210
Convertible debt converted into common shares   20   20
Convertible debt converted into common shares (in shares) 2,858      
Other (in shares) 15      
Net income (loss)     91 91
Ending Balance at Sep. 30, 2021 $ 12 38,385 (14,135) 24,262
Ending Balance (in shares) at Sep. 30, 2021 11,839,304      
Beginning Balances at Dec. 31, 2021 $ 13 43,387 (14,444) 28,956
Beginning Balances (in shares) at Dec. 31, 2021 12,918,866      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Exercise of stock options   4   4
Exercise of stock options (in shares) 800      
Share issuance, net $ 6 5,189   5,195
Share issuance, net (in shares) 5,576,087      
Stock-based compensation   464   464
Stock-based compensation (in shares) 16,852      
Net income (loss)     (8,618) (8,618)
Ending Balance at Sep. 30, 2022 $ 19 49,044 (23,062) 26,001
Ending Balance (in shares) at Sep. 30, 2022 18,512,605      
Beginning Balances at Jun. 30, 2022 $ 13 43,963 (21,629) 22,347
Beginning Balances (in shares) at Jun. 30, 2022 12,919,666      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Share issuance, net $ 6 5,189   5,195
Share issuance, net (in shares) 5,576,087      
Stock-based compensation   (108)   (108)
Stock-based compensation (in shares) 16,852      
Net income (loss)     (1,433) (1,433)
Ending Balance at Sep. 30, 2022 $ 19 $ 49,044 $ (23,062) $ 26,001
Ending Balance (in shares) at Sep. 30, 2022 18,512,605